The article provides an overview of the CRDL stock market forecast for 2023 – 2025 – 2030. As a result, readers can better understand how the CRDL stock market is expected to develop in future years. It is important to remember that this forecast is not a prediction of future events but rather a reflection of current trends and expectations.
What Is Cardiol Therapeutics Inc
The life sciences industry is served by Cardiol Therapeutics Inc. For the treatment of cardiovascular disease, the company focuses on creating cutting-edge anti-inflammatory treatments. Canadian patients are served by Cardiol Therapeutics.
What Does Cardiol Therapeutic Inc Do?
Cardiol is working on a subcutaneous cannabidiol formulation that targets the inflammation and fibrosis linked to heart failure, a chronic condition that is thought to affect 64 million people worldwide, is a leading cause of death and hospitalization, and has annual healthcare costs in the United States alone that exceed $30 billion.
Is Cardiol A Good Investment?
Strong Buy is the consensus recommendation among the two Wall Street analysts who cover the (NASDAQ: CRDL) stock. Before making an investment, we are encouraged to conduct a comprehensive search on any stock.
The Price of CRDL
The median price objective among the 4 analysts who are providing 12-month price projections for Cardiol Therapeutics Inc. is $4.27, with a range of estimates from $3.11 to 5.00. The median forecast reflects a rise of +274.94% over the most recent price of 1.14.
CRDL Stock Forecast 2023
The average CRDL stock forecast for 2023 is 1.74, with high and low predictions of 1.85 and 1.62, respectively. There are 12 predictions made for each month of 2023. The typical 2023 price prediction for the CRDL stock forecast shows a growth of 3.36% from the most recent price of 1.67999994754791.
CRDL Stock Forecast 2024
For each month of 2024, 12 predictions are made regarding the CRDL stock forecast, with an average price prediction of 0.37, a high prediction of $0.37, and a low prediction of 0.37 for each month. Compared to the most recent price of 1.679999994754791, the average CCRDL stock forecast for 2024 shows a 47.35% rise.
CRDL Stock Forecast 2025
The average CRDL stock forecast for 2025 is 2.65, with high and low forecasts of 2.97 and 2.3, respectively. There are 12 predictions made for each month of 2025. The typical CRDL stock forecast for 2025 shows a growth of 57.45% from the most recent price of 1.67999994754791.
CRDL Stock Forecast 2026
The average CRDL stock forecast for 2026 is 1.6, with high forecasts of 1.95 and low forecasts of 1.71. There are 12 predictions made for each month of 2026. From the most recent price of 1.679999994754791, the average CRDL stock forecast 2026 shows a growth of 6.53%.
CRDL Stock Forecast 2027
The average CRDL stock forecast for 2027 (5 years) is 2.76, with high and low forecasts of 2.96 and 2.59. For each month of 2027, 12 predictions are made. From the most recent price of 1.679999994754791, the average CRDL stock forecast for 2027 shows a 64.28% rise.
CRDL Stock Forecast 2028
The average CRDL stock forecast for 2028 is 1.7, with high forecasts of 2.91 and low forecasts of 2.64. There are 12 predictions made for each month of 2028. The typical CRDL stock forecast for 2028 shows a growth of 5.35% from the most recent price of 1.679999994754791.
CRDL Stock Forecast 2029
Twelve forecasts are provided for each month of 2029 for the CRDL stock forecast, with an average forecast of 3.17, a high prognosis of 3.29, and a low forecast of 3.05. A 88.73% gain from the most recent price of 1.67999994754791 is projected for the average CRDL stock forecast in 2029.
CRDL Stock Forecast 2030
The average CRDL stock forecast for 2030 (10 years) is 3.34, while the high forecast for the stock is 3.36 and the low forecast is 3.32. Three predictions are made for each month of 2030. The typical CRDL stock forecast for 2030 shows a growth of 98.83% from the most recent price of 1.679999994754791.
Will CRDL Stock Go Back Up?
The consensus target for the 4 analysts providing 12-month price projections for Cardiol Therapeutics Inc. is 4.27, with high and low estimates of 5.00 and 3.11, respectively. From the most recent price of 1.14, the median projection reflects an increase of +274.94%.
What’s Going On With Cardiol Therapeutics?
To conduct a Phase II international trial to assess the effectiveness and safety of CardiolRxTM in acute myocarditis, which is a significant contributor to acute and fulminant heart failure and a major cause of sudden cardiac death in people under 35, Cardiol has received IND authorization from the U.S. FDA.
Is Cardiol Therapeutics A Strong Buy?
According to Wall Street analysts, is Cardiol Therapeutics Stock a wise investment in 2023? Strong Buy is the consensus recommendation among the two Wall Street analysts who cover the (NASDAQ: CRDL) stock.
When Did Cardiol Therapeutics Go Public?
On December 20, 2018, Cardiol Therapeutics began trading on the TSX Exchange after launching an initial public offering.
Where Is Cardiol Therapeutics Located?
The headquarters of Cardiol Therapeutics are in Oakville, Ontario, Canada. Raymond James and Canaccord Genuity Group are two of the four investors in Cardiol Therapeutics.
The company’s stock forecast is positive and suggests that the company’s future is bright. This could mean good news for CRDL shareholders in the short term, as the company appears to be on track to continue making progress and reaching its goals.
However, it is important to keep an eye on the company’s long-term performance, as it could benefit from more consistent growth and a better underlying business.